Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -4.525% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) Cc1c(Cl)cccc1NC(=O)Nc1ccc(C(N)=O)cc1
b) Cc1ccccc1CN1CCN(S(=O)(=O)c2cccc3nsnc23)CC1
Answer: b. Cc1ccccc1CN1CCN(S(=O)(=O)c2cccc3nsnc23)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1CN1CCN(S(=O)(=O)c2cccc3nsnc23)CC1
Cc1ccccc1CN1CCN(S(=O)(=O)c2cccc3nsnc23)CC1
4-[4-[(2-methylphenyl)methyl]piperazin-1-yl]sulfonyl-2,1,3-benzothiadiazole